BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,420.00
-80.00 (-1.45%)
At close: Jun 13, 2025, 3:30 PM KST
-42.89%
Market Cap 26.36B
Revenue n/a
Net Income n/a
Shares Out 4.86M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend 400.00 (7.38%)
Ex-Dividend Date Dec 27, 2024
Volume 53,894
Average Volume 14,457
Open 5,510.00
Previous Close 5,500.00
Day's Range 5,350.00 - 5,600.00
52-Week Range 4,965.00 - 11,580.00
Beta 0.82
RSI 34.87
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

News

There is no news available yet.